ACET Q2 2017 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$72M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$115M-7.3% YoY

Gross Profit

$39M33.8% margin

Operating Income

$35M30.2% margin

Net Income

$25M22.1% margin

EPS (Diluted)

$15.68

QoQ Revenue Growth

-39.6%

Cash Flow

Operating Cash Flow

$280,000

Free Cash Flow

$538,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$633M

Stockholders' Equity

$405M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$115M	$124M	-7.3%
Gross Profit	$39M	$27M	+45.4%
Operating Income	$35M	$10M	+238.2%
Net Income	$25M	$5M	+361.8%

Revenue Segments

Human Health

$114M58%

Performance Chemicals

$45M23%

Pharmaceutical Ingredients

$36M19%